Cargando…

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention

BACKGROUND: In patients with non‐ST‐segment elevation acute coronary syndromes, inhibition of platelet aggregation (IPA) with a potent P2Y(12) inhibitor, ticagrelor, was inferior to tirofiban infusion at 2 hours, indicating that glycoprotein IIb/IIIa inhibitors are still needed. Ticagrelor and eptif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marian, Moazez J., Alli, Oluseun, Al Solaiman, Firas, Brott, Brigitta C., Sasse, Mark, Leesar, Tara, Prabhu, Sumanth D., Leesar, Massoud A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669172/ https://www.ncbi.nlm.nih.gov/pubmed/28611098 http://dx.doi.org/10.1161/JAHA.117.005562

Ejemplares similares

Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial
por: Marian, Moazez J., et al.
Publicado: (2019)

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018)

Clinical and economic studies of eptifibatide in coronary stenting
por: Pasala, Tilak, et al.
Publicado: (2014)

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes
por: Shah, Ibrahim, et al.
Publicado: (2010)

Efficacy of intravenous eptifibatide in primary percutaneous coronary intervention patients
por: Jalalian, Rozita, et al.
Publicado: (2021)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Publicado: (2014)

Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010)

A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021)

Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery
por: Boettcher, Brent T., et al.
Publicado: (2016)

Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction
por: Weinreich, Michael, et al.
Publicado: (2014)

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia
por: Byrne, John, et al.
Publicado: (2015)

How Safe is Eptifibatide during Urgent Carotid Artery Stenting?
por: Allam, Hesham, et al.
Publicado: (2013)

Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014)

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation
por: Shariati, Hooman, et al.
Publicado: (2016)

Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020)

Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022)

Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction
por: Shemirani, Hasan, et al.
Publicado: (2019)

Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021)

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells
por: Hajtuch, Justyna, et al.
Publicado: (2022)

Successful Treatment of a Left Main Thrombus by Intracoronary Eptifibatide Infusion in a 36-Year-Old Patient
por: Alipour-Parsa, Saeed, et al.
Publicado: (2016)

Metabolism of ticagrelor in patients with acute coronary syndromes
por: Adamski, Piotr, et al.
Publicado: (2018)

RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect
por: Bardania, Hassan, et al.
Publicado: (2019)

Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Jalalian, Rozita, et al.
Publicado: (2023)

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
por: Johnson, Thomas W., et al.
Publicado: (2020)

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
por: Birkeland, Kade, et al.
Publicado: (2010)

Critical appraisal of ticagrelor in the management of acute coronary syndrome
por: Nawarskas, James J, et al.
Publicado: (2011)

Assessment of Eptifibatide Dosing in Renal Impairment Before and After In-Service Education Provided by Pharmacists
por: Donovan, Jennifer L., et al.
Publicado: (2007)

Jailing polymer jacketed guide-wires during bifurcation coronary interventions is associated with procedural myocardial infarction
por: Chatterjee, Arka, et al.
Publicado: (2017)

Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
por: Namazi, Mohammad Hasan, et al.
Publicado: (2013)

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor
por: Parodi, Guido, et al.
Publicado: (2015)

Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion
por: Bertuglia, Silva, et al.
Publicado: (2002)

Local Intracoronary Eptifibatide versus Mechanical Aspiration in Patients with Acute ST-Elevation Myocardial Infarction
por: Hamza, Mohamed A., et al.
Publicado: (2014)

Eptifibatide use in ischemic stroke patients undergoing endovascular thrombectomy: A matched cohort analysis
por: Rana, Ameena, et al.
Publicado: (2022)

Treatment of progressive ischemic stroke with low‑dose eptifibatide: A retrospective case‑control study
por: Luo, Long, et al.
Publicado: (2022)

Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice
por: Tonin, Gašper, et al.
Publicado: (2023)

Effect of intravenous dexmedetomidine administered as bolus or as bolus-plus-infusion on subarachnoid anesthesia with hyperbaric bupivacaine
por: Kavya, Upadhya R, et al.
Publicado: (2018)

Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial
por: Elbadawi, Ayman, et al.
Publicado: (2016)

A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study
por: Hibbert, Benjamin, et al.
Publicado: (2014)

Eptifibatide-Induced Severe Thrombocytopenia After ST-Elevation Myocardial Infarction (STEMI): A Case Report
por: Gheith, Zaid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ue3b211mlv2t1eaeb8hkuqh42